🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sudeep Kumar

Institute of Medical Sciences

ORCID: 0000-0003-0960-8162

Also affiliated with Albany Medical Center Hospital, Banaras Hindu University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection”.

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection

Vaccines(2020)10.3390/vaccines8020193
N/A
0DataRank · unranked
8 citations

Raju Sunagar, Edmund J. Gosselin, Sudeep Kumar

Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity

Pathogens(2020)10.3390/pathogens9050375
N/A
0DataRank · unranked
4 citations

Lauren E. Shoudy, Donald Steiner, Sudeep Kumar, Sarah J. Rosa, Prachi Namjoshi +5 more

The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection

Pathogens(2021)10.3390/pathogens10121646
N/A
0DataRank · unranked
6 citations

Prachi Namjoshi, Gabriela F. Giordano, Sudeep Kumar, Jennifer D. Bowling, H. Carl Gelhaus +8 more

A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection

Mucosal Immunology(2024)10.1016/j.mucimm.2024.01.002
N/A
0DataRank · unranked
13 citations

Peng Li, Shreya Das, Tanvir Noor Nafiz, Sudeep Kumar, Guangchun Bai +7 more

Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens

Vaccine(2025)10.1016/j.vaccine.2025.126729
N/A
0DataRank · unranked
1 citations

Karsten R. O. Hazlett, Guangchun Bai, Sudeep Kumar